Institute for Myeloma & Bone Cancer Research Announces Publication in Targeted Oncology

Longest Survival Reported to Date for Multiple Myeloma Patients WEST HOLLYWOOD, Calif., Sept. 19, 2023 /PRNewswire/ — The Institute for Myeloma & Bone Cancer Research (IMBCR) announces the publication in Targeted Oncology on the outstanding survival of 161 unselected, new patients with…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.